Jodi Dodson
Women's Health · Norman, OKNPI 1003986563
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 55 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 10 manufacturers reported payments, led by Mayne Pharma Commercial LLC at 35.6% of the total.
Across 55 payments — averaging $13.71 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Mayne Pharma Commercial LLC$269
- AbbVie$208
- Antares Pharma, Inc.$98
- Sumitomo Pharma America, Inc.$46
- Astellas Pharma US Inc$44
- Avion Pharmaceuticals$23
- plus $66 from 4 others
What the payments were for
- Food & beverage$754100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Mayne Pharma Commercial LLC | 25 | $269 |
| AbbVie | 16 | $208 |
| Antares Pharma, Inc. | 5 | $98 |
| Sumitomo Pharma America, Inc. | 2 | $46 |
| Astellas Pharma US Inc | 2 | $44 |
| Avion Pharmaceuticals | 1 | $23 |
| Intra-sana Laboratories | 1 | $18 |
| Idorsia Pharmaceuticals US Inc | 1 | $17 |
| Boehringer Ingelheim | 1 | $16 |
| Pfizer | 1 | $16 |
How this compares
$754 in reported general payments places this provider in the 65th percentile of 62 women's health providers in Oklahoma.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| ProgesteroneProgesterone, Micronized | 18 | $1,622 |
| Estradiol | 19 | $687 |
Paid to pharmacies, not to this prescriber.
Other women's health in Norman
- Lilly FerrellNorman$2K
- Amber ScrogginsNorman$2K
- Audra StanfieldNorman$1K
- Jennifer WestNorman$468
- Sheila MetzgerNorman$363
- Hilary MillerOklahoma City$38K
- Beverly CotnerOklahoma City$4K
- April ZumwaltTulsa$4K
- Kerri VandiverTulsa$3K
- Whitney HunterOklahoma City$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.